The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 15.00 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 127.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

Thu, 25th Mar 2021 14:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Safestyle UK PLC - Bradford-based retailer and manufacturer of PVCu replacement windows - Revenue for 2020 falls 10% to GBP113.2 million while pretax loss widens to GBP6.2 million from GBP3.8 million. Says 2020 saw "huge levels" of disruption and sustained uncertainty due to the pandemic, with results hit by the cessation of business operations between March and the end of May, though business was able to capture strong momentum in the second half. Adds that as a result of encouraging start to 2021, financial performance for the year ahead expected to be above market expectations. Board expects to revisit its dividend policy later in 2021, assuming that the group has returned to a consistent delivery of profitability. "Having taken decisive action to support the business during the period, we saw a strong recovery in the second half of the year with good order intake growth and a step up in operational capacity, as customer demand remained robust. By the end of 2020, our order book was 83% larger than 2019's closing position, which has given us a strong platform to maintain momentum at the beginning of the current financial year in spite of the external disruption," says Chief Executive Mike Gallacher.

----------

Tandem Group PLC - sports equipment distributor based in West Midlands, England - Revenue for 2020 falls 4.6% to GBP37.1 million but pretax profit jumps to GBP4.0 million from GBP2.5 million. Gross profit margin rose to 32.9% from 30.4%. "This reflected the strong domestic demand for products across the ranges and was achieved by controlling supplier cost prices, re-sourcing product where necessary, discontinuing low margin product lines and introducing new, more profitable products. There was also very little discounting necessary during the year," company notes. Says stock availability, although slower than hoped for, improved towards the end of the year to enable a strong finish to 2020 for all parts of the cycling businesses. Proposes final dividend of 5.50 pence per share, bringing total for year to 8.62p, up from 6.60p in 2019. "We remain mindful of macro-economic uncertainties and the challenges that we have highlighted but with an excellent start to 2021 and a very strong order book we expect to achieve turnover growth and we continue to be confident that we will deliver another year of profitability to our shareholders," company says.

----------

ProPhotonix Ltd - manufacturer of LED illumination systems - Revenue for 2020 falls to USD13.6 million from USD15.0 million in 2019, with pretax profit tumbling to USD671,000 from USD1.1 million. However, net income rises to USD1.1 million from USD996,000 after an income tax benefit of USD421,000. "Overall, we are pleased with the year 2020. Though our revenue declined by 9%, largely from Covid-19, we were able to mitigate the reduction with an outstanding result. Most importantly, cash ended the year at USD2.6 million, representing an increase of USD1.1 million," Chief Executive & President Tim Losik says.

----------

Schroder Asian Total Return Investment Co PLC - invests in equities and equity-related securities of companies trading in the Asia Pacific region, excluding Japan - Says produced "excellent" performance despite challenging year for global stock markets. During 2020, net asset value total return was 34%, outperforming reference index which returned 19%. "The company once again outperformed the peer group, which produced an average total return of 30.9% for the year. Stock selection has proved key to the Company's strong performance," company says. Net asset value per share at end of 2020 479.07p, up from 365.57p a year before.

----------

Genedrive PLC - molecular diagnostics firm - Revenue & other income for six months to end of December falls to GBP355,000 from GBP627,000 a year ago, though swings to pretax profit of GBP621,000 from GBP3.3 million loss. Registers finance income of GBP3.6 million on conversion of loan notes, compared with finance expense of GBP765,000 a year ago. "Of total revenues, the vast majority was related to our pathogen detection assay sold to the Department of Defence with small additional amounts on HCV, grant income and some early plate sales of our 96-SARS-COV 2 kit," company says. Adds that post-period end contract with Beckman and the on-going opportunity with a European Ministry of Health provide firm with optimism for the remainder of the financial year.

----------

Sabien Technology Group PLC - Maidenhead, England-based energy efficiency technology group - Revenue for half-year to December 31 jumps to GBP412,000 from GBP159,000 while pretax loss slims to GBP310,000 from GBP516,000. Says trading encouraging in six-month period. "Post year end, it was pleasing to win a further significant order, worth approximately GBP400,000, from one of Sabien's major public sector customers," company says, adding it remains confident in the business's future success.

----------

JPMorgan Smaller Companies Investment Trust PLC - a trust giving access to growing smaller companies in the UK - Reports net asset total return of 31% over six months to the end of January, outperforming the Numis Smaller Companies plus AIM (excluding Investment Trusts) Index which rose by 29%. "The greater return for shareholders reflects a significant narrowing of the share price discount to net asset value from 13.7% at the start of the financial year to 6.0% at the end of the half year. It is gratifying, and perhaps surprising, to note that your company's net asset value has comfortably surpassed the pre Covid levels and made a new all time high during the period," trust notes. NAV per share 345.6p at end of January, versus 321.5p a year ago.

----------

Regional REIT Ltd - UK-focused real estate investment trust - EPRA net tangible assets 98.6 per share at end of 2020, down from 112.6p a year ago. Total rent collection or within terms for 2020 was 98.2% of rent due, similar to the 99.4% collected for the equivalent period in 2019. Rent roll remained stable at GBP64.2 million versus GBP64.3 million. Declared dividends totalling 6.40p for 2020, down from 8.25p for 2019. "It should be highlighted that, looking ahead, there is a clear aspiration by the board to maintain its record of uninterrupted quarterly dividend payments, especially through this period of continuing uncertainty. This is predicated on the strength of the Company's balance sheet and the strong rent collections received throughout the year," company says.

----------

Journeo PLC - information systems and transport technical services company - Revenue for 2020 rises 19% to GBP13.6 million from GBP11.4 million in 2019, with firm turning to pretax profit of GBP193,000 from GBP948,000 loss. Passenger sales increased by 43% to GBP6.8 million. Says 2021 has started encouragingly, with purchase orders and contract awards valued at GBP4.2 million announced during the first quarter. "There is also a rising level of enquiries and sales opportunities in our pipelines, which are now predominantly based upon our own IP, technologies, and software," Journeo adds.

----------

Faron Pharmaceuticals Oy - Finland-based biopharmaceutical company - Pretax loss for 2020 widens to EUR16.9 million from EUR13.3 million year-on-year, with no revenue reported for either period. Research & development expenses increase to EUR13.8 million from EUR10.2 million. Says 2020 was year of "significant activity" with company's focus on pipeline delivery continuing "unabated". "The Company's successful fundraising in 2020 and, post period, in February this year, puts us in a strong position to continue the progress of our pipeline and brings us closer to our goal of developing ground-breaking new treatments from our unique scientific discoveries. I'd like to thank our shareholders for their continued support and the entire team at Faron for their exceptional efforts during a challenging year," says Chief Executive Markku Jalkanen.

----------

TMT Investments PLC - venture capital investor in high-growth technology companies - Net asset value per share USD6.10 at end of 2020, up 73% from USD3.52 at end of 2019. Notes that NAV benefited from increased valuations in three of its significant holdings: sales CRM company Pipedrive, ride-hailing and food delivery company Bolt and cloud storage company Backblaze. "2020 was the most successful year for the company to date, recording a large number of significant revaluations across the portfolio, led by TMT's second multi-million cash exit when TMT exited its stake in Pipedrive to Vista Equity Partners for USD41 million. The Pipedrive exit generated a total cash return of over 51 times on TMT's original investments in Pipedrive, a superb return for shareholders," says Executive Director Alexander Selegenev.

----------

Surgical Innovations Group PLC - Leeds-based technology for minimally invasive surgery - Revenue for 2020 falls to GBP6.3 million from GBP10.7 million in 2019, with pretax loss widening to GBP3.3 million from GBP2.6 million. Says revenue hit by the pandemic, which had an adverse impact on the level of elective surgery carried out in all major markets and across all product areas, though adds that trading recovered strongly in the third quarter until the resurgence of a second wave of infections at the end of the year. Chair Nigel Rogers says: "Trading in the first two months of the current year continues to be constrained by the effects of the Covid-19 pandemic. Despite this, group revenue is 11% ahead of the corresponding period last year; a period in which our key markets were largely unaffected. This indicates the continuing resilience of the business, however, given the continued uncertainty of the global pandemic, we will look to reinstate guidance at a later date when there is greater clarity on the timing of the expected recovery in elective surgery from our partners and customers."

----------

Venture Life Group PLC - Bracknell, Berkshire-based consumer health products - Revenue for 2020 increases to GBP30.1 million from GBP20.2 million, while pretax profit more than doubles to GBP3.3 million from GBP1.4 million. Deems 2020 an "exceptional year", which began with good momentum from 2019 and was furthered by the launch of the Disinplus brand in March 2020, a newly developed hand sanitising gel. "2020 was an outstanding year of performance for the business, and despite the first quarter of 2021 seeing most markets in lockdown, we look forward to 2021 with confidence," says Chief Executive Jerry Randall.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Mar 2023 10:42

Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O'Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.

Read more
29 Mar 2023 09:38

Faron Pharmaceuticals names James O'Brien as CFO

(Sharecast News) - Drug discovery and development company Faron Pharmaceuticals has tapped James O'Brien to take over as its new chief financial officer.

Read more
22 Mar 2023 17:12

Faron Pharmaceuticals gets positive feedback from FDA meeting

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.

Read more
17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

Monday 20 March 
Aukett Swanke Group PLCGM re proposed acquisition of Torpedo Factory Group Ltd
Pantheon Resources PLCAGM
Voyager Life PLCGM re subscription and fundraise
Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
Zaim Credit Systems PLCGM re director removal and name change
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Mar 2023 11:53

Faron Pharmaceuticals annual loss widens on higher research costs

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts.

Read more
24 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Monday 27 February 
Associated British Foods PLCTrading Statement
Beeks Financial Cloud Group PLCHalf Year Results
Bunzl PLCFull Year Results
Centralnic Group PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
DX Group PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Kosmos Energy LtdFull Year Results
Quartix Technologies PLCFull Year Results
RHI Magnesita NVFull Year Results
Senior PLCFull Year Results
Tuesday 28 February 
abrdn PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Bluefield Solar Income Fund LtdHalf Year Results
boohoo Group PLCFull Year Results
Cap-XX LtdHalf Year Results
Croda International PLCFull Year Results
Dalata Hotel Group PLCFull Year Results
Derwent London PLCFull Year Results
Hutchmed (China) LtdFull Year Results
Intertek Group PLCFull Year Results
Kitwave Group PLCFull Year Results
Man Group PLCFull Year Results
McBride PLCHalf Year Results
Morgan Advanced Materials PLCFull Year Results
Ocado Group PLCFull Year Results
Princess Private Equity Holding LtdFull Year Results
Rotork PLCFull Year Results
Serco Group PLCFull Year Results
St James's Place PLCFull Year Results
S-Ventures PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Videndum PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 1 March 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
GetBusy PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Global Invacom Group LtdFull Year Results
Haydale Graphene Industries PLCHalf Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
Permanent TSB Group Holdings PLCFull Year Results
Persimmon PLCFull Year Results
Rathbones Group PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Ricardo PLCHalf Year Results
Weir Group PLCFull Year Results
Thursday 2 March 
Alfa Financial Software Holdings PLCFull Year Results
Apax Global Alpha LtdFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Cairn Homes PLCFull Year Results
Capita PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Grafton Group PLCFull Year Results
Haleon PLCFull Year Results
Hunting PLCFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Metro Bank PLCFull Year Results
National Express Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder AsiaPacific Fund PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Friday 3 March 
Avation PLCHalf Year Results
Faron Pharmaceuticals LtdFull Year Results
IMI PLCFull Year Results
Pacific Horizon Investment Trust PLCHalf Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
27 Jan 2023 18:56

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Jan 2023 10:28

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023.

Read more
27 Jan 2023 10:11

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jan 2023 16:26

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 12:06

Faron Pharmaceuticals sees patient remission in immunotherapy trials

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function.

Read more
1 Dec 2022 21:42

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Nov 2022 19:49

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
31 Oct 2022 19:58

TRADING UPDATES: 4Global wins deal; James Cropper profit warning

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
14 Oct 2022 11:14

Faron Pharmaceuticals shares down as raises EUR8.4 million in placing

(Alliance News) - Faron Pharmaceuticals Ltd shares declined on Friday, after it said it has raised EUR8.4 million from a share placing.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.